✦ LIBER ✦

368: Longer follow up of patients (pts) with advanced chronic lymphocytic leukemia (CLL) treated with nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT)

✍ Scribed by M.L. Sorror; B. Storer; B.M. Sandmaier; M.B. Maris; J. Shizuru; D. Niederwieser; E. Agura; T. Chauncey; R. Maziarz; M. Pulsipher; P. McSweeney; J. Wade; B. Bruno; A. Langston; K. Blume; R. Storb; D.G. Maloney

Book ID: 116279548
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 71 KB
Volume: 13
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2006.12.373

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of patients (pts) with chemoth

Treatment of patients (pts) with chemotherapy-refractory chronic lymphocytic leukemia (CLL) with nonmyeloablative (NM) conditioning and hematopoietic cell transplantation (HCT) from HLA-matched related (MRD) or unrelated donors (URD)

✍ M.L. Sorror; M.B. Maris; B.M. Sandmaier; M. Jain-Stuart; B. Storer; U. Hegenbart 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Early Results of a Phase II Study Adding

Early Results of a Phase II Study Adding Peri-Transplant Rituximab to Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients (PTS) with High-Risk Fludarabine-Refractory Chronic Lymphocytic Leukemia (Cll)

✍ M.L. Sorror; B. Storer; B.M. Sandmaier; T. Chauncey; B. Bruno; N.N.S. Andersen; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Fludarabine with cytarabine followed by

Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia

✍ Marta Krejci, Michael Doubek, Yvona Brychtova, Olga Stehlikova… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 180 KB

Characterization of graft-versus-leukemi

Characterization of graft-versus-leukemia responses in patients treated for advanced chronic lymphocytic leukemia with donor lymphocyte infusions after in vitro T-cell depleted allogeneic stem cell transplantation following reduced-intensity conditioning

✍ Hoogendoorn, M; Jedema, I; Barge, R M Y; van Luxemburg-Heijs, S A P; Beaumont, F 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 170 KB

Pre-Transplant Azacitidine and Allogenei

Pre-Transplant Azacitidine and Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes of One Hundred Fifty-Nine Patients up to Age Seventy-Five with Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

✍ Field, Teresa; Perkins, Janelle; Hillgruber, Ryan; Nishihori, Taiga; Tomblyn, Ma 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Long term follow-up of Asian patients wi

Long term follow-up of Asian patients with chronic myeloid leukemia (CML) receiving allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-identical sibling—evaluation of risks and benefits

✍ L.P. Koh; W.Y.K. Hwang; C.H. Tan; Y.C. Linn; Y.T. Goh; C.T.H. Chuah; H.J. Ng; S. 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 222 KB